Aehr Test Systems (AEHR) has drawn fresh attention after its recent share move, with the stock closing at US$99.50 and returns over the past month and past 3 months standing out for investors.

Despite the latest session’s share price falling 6.43%, Aehr Test Systems still carries strong momentum, with a 30 day share price return of 35.89% and a year to date share price return of 349%, while the 1 year total shareholder return is very large.

If rapid moves in semiconductor testing stocks have your attention, this could be a good moment to look wider and check out 42 AI infrastructure stocks

With Aehr Test Systems posting a very large 1 year total shareholder return and trading above the average analyst price target, the key question now is whether markets have already priced in future growth or if there is still an opportunity for investors to add exposure.

Most Popular Narrative: 445% Overvalued

Aehr Test Systems last closed at $99.50, while the most followed narrative on the stock, according to Arkus, places fair value closer to $18.27 using a discounted cash flow style framework with a specific discount rate.

AEHR may still have attractive technology and exposure to semiconductor growth markets. But the capital allocation record deserves as much scrutiny as the product story.

For shareholders, the real story may not be burn-in systems or AI demand.

Want to understand why a strong revenue growth outlook sits next to an aggressive fair value cut? The narrative leans heavily on margin assumptions and future profit benchmarks that may surprise you.

Result: Fair Value of $18.27 (OVERVALUED)

However, this bearish narrative still faces risks, including any shift in insider activity or a sustained improvement in margins and revenue that challenges the current fair value assumptions.

Next Steps

The split between concerns and optimism in this article is clear. Check the underlying figures soon and decide where you stand on the stock’s 1 key reward and 2 important warning signs.

Looking for more investment ideas?

If this story has you thinking about your next move, do not stop here, use the screener to line up your next set of candidates.

• Target quality at a discount by scanning 50 high quality undervalued stocks that combine solid fundamentals with prices that may not fully reflect their strengths.
• Prioritise resilience by checking 66 resilient stocks with low risk scores designed for investors who want steadier profiles and fewer unpleasant surprises.
• Hunt for promising outliers by reviewing the screener containing 22 high quality undiscovered gems before other investors start paying closer attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.